Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, December 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bigneat Announces Optiflow, a New Style of Safety Workstation
Tuesday, November 25, 2014
Recirculatory filtration fume system has consistent airflow ensuring the integrity of the ‘working safe-zone’ and providing the user with unhindered accessibility.

Asynt PressureSyn Wins Innovation Award
Tuesday, November 18, 2014
A high pressure reactor designed to work on any magnetic hotplate stirrer.

Immersion Coolers for Flexible Cooling Down to -100 °C
Friday, November 07, 2014
A flexible solution for a variety of cooling applications.

New Precision Balances: Reliable, Compliant and Intuitive
Monday, November 03, 2014
METTLER TOLEDO's Excellence XPE precision balances make daily weighing tasks fast, easy and error-free.

Versatile Evaporator for Lab & Batch Processing Tasks
Friday, October 17, 2014
New Rocket Synergy series offers automated evaporation of a wide range of sample formats and sizes.

Manifold Ensures Safe Secure & Efficient Reaction Cooling
Friday, October 17, 2014
Asynt’s DrySyn water manifold will keep the condenser tubing safe, secure and tidy.

Oerlikon Leybold Vacuum Moves Offices in the Netherlands
Thursday, October 16, 2014
New premises offer growth opportunities.

Anyone for Coffee?
Saturday, October 11, 2014
Heidolph rotary evaporator features in C4 Gadget Man show.

Micro Droplet Systems from Dolomite
Saturday, October 04, 2014
Provide automatic, seamless production of monodispersed droplets.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 921
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn